General Information of the Compound
| Compound ID |
CP0065731
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3aS,5R,6R,6aS,9aR,9bR)-6-ethyl-1-propyl-2,3,3a,4,5,6,6a,7,8,9,9a,9b-dodecahydrobenzo[de]quinolin-5-ol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H31NO
|
||||||||||||||||||
| Molecular Weight |
265.441
|
||||||||||||||||||
| Canonical SMILES |
CCCN1CC[C@H]2C[C@@H](O)[C@H](CC)[C@H]3CCC[C@@H]1[C@H]23
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H31NO/c1-3-9-18-10-8-12-11-16(19)13(4-2)14-6-5-7-15(18)17(12)14/h12-17,19H,3-11H2,1-2H3/t12-,13+,14+,15+,16+,17+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PJZSTWQBLPHXET-XXJXLTMMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor